email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
961 - 975
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Innovent/Lilly PD-1 Rejected by US FDA Panel; Lilly Says Price 40% Below Competition
$5.00
Available
Zerun Bio Lands CEPI Grant to Start Trials of Multi-Variant COVID Vaccine
$5.00
Available
Innovent/Lilly Face US FDA Setback Due to China-Only PD-1 Trials
$5.00
Available
Huadong Med Acquires Rights To Bi-functional Immunotherapy in $75 Million Deal
$5.00
Available
EdiGene to Discover Stem Cell/Natural Killer CAR Therapy for Neukio
$5.00
Available
Ascletis Approved to Start US Trials of an Oral PD-L1 for Solid Tumors
$5.00
Available
CANbridge Says C5 mAb Effective in Early Trial for Complement Diseases
$5.00
Available
Antengene Approved to Start Trial of Oral CD73 Inhibitor for Solid Tumors
$5.00
Available
Xvivo Perfusion Approved to Launch Lung Transplant Product in China
$5.00
Available
Hutchmed Starts China Trial of Novel FGFR Inhibitor in Solid Tumor Cancers
$5.00
Available
Kintor Starts US Trial of Topical Androgen Inhibitor for Alopecia
$5.00
Available
Beroni Group to Build Biopharma R&D Facility in Zhuhai Park
$5.00
Available
Dizal Pharma Awarded US Breakthrough Status for NSCLC Therapy
$5.00
Available
HanBio Raises $40 Million for BiSpecific Antibody Portfolio
$5.00
Available
Akeso Starts Phase III Trial of Bispecific Immunotherapy for NSCLC
$5.00
Available